Results 161 to 170 of about 1,540,630 (392)
Macrophage HM13/SPP Enhances Foamy Macrophage Formation and Atherogenesis
Aryl Hydrocarbon Receptor‐Interacting Protein (AIP) reduces macrophage cholesterol‐ester accumulation and may prevent atherogenic foamy macrophage formation.
Yu Cao+15 more
doaj +1 more source
A STUDY OF THE MACROPHAGE REACTION IN THE PULMONARY LESIONS OF DOGS WITH EXPERIMENTAL PNEUMOCOCCUS LOBAR PNEUMONIA [PDF]
O. H. Robertson, Clayton G. Loosli
openalex +1 more source
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang+16 more
wiley +1 more source
THE PARTICULATE HYDROLASES OF MACROPHAGES [PDF]
Zanvil A. Cohn, Edith Wiener
openalex +1 more source
Metabolic Consequences of Rheumatoid Arthritis
Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry+2 more
wiley +1 more source
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla+13 more
wiley +1 more source
Editorial: Macrophage Metabolism and Immune Responses
Héctor Rodríguez+6 more
doaj +1 more source
Inhibition of Spleen Cell DNA Synthesis by Autologous Macrophages [PDF]
R. M. E. Parkhouse, Richard Dutton
openalex +1 more source